Fulcrum Therapeutics, Inc. (FULC)
NASDAQ: FULC · Real-Time Price · USD
4.350
+0.320 (7.94%)
Dec 20, 2024, 4:00 PM EST - Market closed
Fulcrum Therapeutics Market Cap
Fulcrum Therapeutics has a market cap or net worth of $234.63 million as of December 20, 2024. Its market cap has decreased by -23.48% in one year.
Market Cap
234.63M
Enterprise Value
-13.46M
1-Year Change
-23.48%
Ranking
Category
Stock Price
$4.35
Market Cap Chart
Since July 18, 2019, Fulcrum Therapeutics's market cap has decreased from $301.64M to $234.63M, a decrease of -22.22%. That is a compound annual growth rate of -4.52%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 234.63M | -43.77% |
| Dec 29, 2023 | 417.30M | 10.13% |
| Dec 30, 2022 | 378.93M | -47.15% |
| Dec 31, 2021 | 716.95M | 124.42% |
| Dec 31, 2020 | 319.46M | -14.89% |
| Dec 31, 2019 | 375.37M | 24.44% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BGM Group | 231.43M |
| Cardiff Oncology | 230.64M |
| Ocugen | 226.94M |
| Aurora Cannabis | 224.65M |
| Nautilus Biotechnology | 223.50M |
| Alpha Tau Medical | 220.25M |
| Precigen | 220.18M |
| Profound Medical | 217.45M |